Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-11-15 10:33 am Unchanged | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | 0 (Unchanged) | View |
2024-11-14 9:46 pm Unchanged | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | 0 (Unchanged) | View |
2024-11-14 7:02 pm Sale | 13G | DELCATH SYS INC DCTH | Vivo Opportunity Fund Holdings L.P. | 1,708,579 5.300% | -1,000,000 (-36.92%) | View |
2024-11-14 4:21 pm Sale | 13G | DELCATH SYS INC DCTH | BIOTECHNOLOGY VALUE FUND L P | 1,041,667 3.600% | -1,296,759 (-55.45%) | View |
2024-11-08 4:51 pm Sale | 13G | DELCATH SYS INC DCTH | HIRSCHMAN ORIN | 1,472,312 4.600% | -67,326 (-4.37%) | View |
2024-05-17 12:48 pm Sale | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,763,468 9.900% | -188,734 (-6.39%) | View |
2024-03-25 6:55 pm Purchase | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,952,202 9.900% | 541,678 (+22.47%) | View |
2024-02-14 10:08 am Purchase | 13G | DELCATH SYS INC DCTH | BIOTECHNOLOGY VALUE FUND L P | 2,338,426 9.990% | 776,912 (+49.75%) | View |
2024-02-13 5:00 pm Sale | 13G | DELCATH SYS INC DCTH | Vivo Opportunity Fund Holdings L.P. | 2,708,579 9.990% | -2,172,162 (-44.50%) | View |
2024-02-13 4:26 pm Sale | 13G | DELCATH SYS INC DCTH | Stonepine Capital Management LLC | 208,333 0.900% | -767,675 (-78.65%) | View |
2024-02-02 09:37 am Sale | 13G | DELCATH SYS INC DCTH | Soleus Capital Master Fund L.P. | 0 0.000% | -806,420 (Position Closed) | View |
2024-01-09 08:12 am Purchase | 13G | DELCATH SYS INC DCTH | HIRSCHMAN ORIN | 1,539,638 6.800% | 1,539,638 (New Position) | View |
2023-11-28 4:53 pm Sale | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,410,524 9.900% | -102,227 (-4.07%) | View |
2023-08-16 4:30 pm Purchase | 13G | DELCATH SYS INC DCTH | Soleus Capital Master Fund L.P. | 806,420 5.300% | 806,420 (New Position) | View |
2023-06-26 5:03 pm Purchase | 13G | DELCATH SYS INC DCTH | Stonepine Capital Management LLC | 976,008 8.700% | 976,008 (New Position) | View |
2023-06-22 4:47 pm Purchase | 13G | DELCATH SYS INC DCTH | BIOTECHNOLOGY VALUE FUND L P | 1,561,514 9.990% | 1,561,514 (New Position) | View |
2023-06-22 4:30 pm Purchase | 13G | DELCATH SYS INC DCTH | Vivo Opportunity Fund Holdings L.P. | 4,880,741 9.990% | 4,880,741 (New Position) | View |
2022-12-29 5:27 pm Sale | 13G | DELCATH SYS INC DCTH | Flynn James E | 0 0.000% | -500,000 (Position Closed) | View |
2022-12-21 12:17 pm Purchase | 13D | DELCATH SYS INC DCTH | Rosalind Advisors Inc. | 2,512,751 9.900% | 692,042 (+38.01%) | View |
2022-12-16 5:07 pm Purchase | 13D | DELCATH SYS INC DCTH | MICHEL GERARD J | 676,477 6.700% | 133,865 (+24.67%) | View |